Considerations for Combination Vaccine Development and Use in the Developing World
Open Access
- 15 December 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (s4) , S340-S345
- https://doi.org/10.1086/322571
Abstract
As more vaccines are developed and become available, combination vaccines will provide a way of delivering multiple antigens to avoid multiple injections and complications in the regular immunization schedules. The advantages of combination vaccines are that they decrease the discomfort of vaccine recipients and parents and also reduce the delivery cost of vaccines. We address some of the issues related to the use of combination vaccines in the developing world. Which vaccines are needed? Do developing countries have the appropriate infrastructure to deliver them? Can vaccines become affordable for countries with low incomes? And what is really needed to achieve the goal of providing developing countries with new vaccines of epidemiologic significance in a timely fashion?Keywords
This publication has 16 references indexed in Scilit:
- Review of regional measles surveillance data in the Americas, 1996–99The Lancet, 2000
- Comparison of separate and mixed administration of DTPw-HBV and Hib vaccines: Immunogenicity and reactogenicity profilesInternational Journal of Infectious Diseases, 1997
- Immune response to a combined hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine administered to infants at 2, 4 and 6 months of ageVaccine, 1997
- Prospects for the use of new vaccines in developing countries: cost is not the only impedimentVaccine, 1996
- Combination Vaccines for Diphtheria, Tetanus, Pertussis, and Haemophilus influenzae Type bAnnals of the New York Academy of Sciences, 1995
- Epidemiological Views into Possible Components of Paediatric Combined Vaccines in 2015Biologicals, 1994
- Combination vaccinesThe Pediatric Infectious Disease Journal, 1994
- World Development Report 1993Published by World Bank ,1993
- Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccineJAMA, 1992
- Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infantsThe Pediatric Infectious Disease Journal, 1991